Please login to the form below

Not currently logged in
Email:
Password:

Peter Nightingale appointed as chair of new MHRA committee

Was formerly president of the Intensive Care Society

edit-MHRA-Peter-Nightingale-2Dr Peter Nightingale has been named as chairman of the MHRA's new Devices Expert Advisory Committee (DEAC).

The DEAC has been formed as a consequence on an independent review on MHRA access to clinical advice and engagement with the clinical community and will replace the Committee on the Safety of Devices.

Commenting on his appointment, Nightingale said: “I am delighted to be taking on this role. The new committee will play a vital role in providing expert advice for the MHRA on a huge range of medical issues and will help to ensure safe use and management of medical devices.”

Nightingale is a consultant in anaesthesia and intensive care medicine and was president of the Royal College of Anaesthetists until September 2012. He was also formerly president of the Intensive Care Society and vice chair of the Academy of Medical Royal Colleges.

John Wilkinson, MHRA Devices director, added: “I am delighted that Dr Nightingale has accepted this appointment at a time when the agency is busy implementing the recommendations of the review chaired by Professor Terence Stephenson into access to clinical advice.

“His expertise and experience will be invaluable in helping the agency as it responds to the demands of the future.”

2nd March 2015

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...